For many children, asthma can be a constant specter, with attacks at the most inconvenient and terrifying times. New research ...
Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.
Everyday Health on MSN
Should You Limit or Avoid Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) With Crohn’s Disease?
While nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen may help some with Crohn’s in the short term, they can ...
As with other drugs, Tarpeyo (budesonide) can cause side effects, such as swelling of the hands, legs, ankles, or feet and high blood pressure. If these side effects become difficult to tolerate, talk ...
Vietnam Investment Review on MSN
Chance Pharma Announces Commercialization Agreement with Huadong Medicine for Innovative Respiratory Drug CXG87
Chance Pharmaceuticals ("Chance" or "Chance Pharma"), a clinical-stage biotechnology company dedicated to the research and development of innovative inhalation therapies, today announced that it has ...
In the first randomised controlled trial to investigate the use of a two-in-one inhaler as the sole reliever therapy for ...
AstraZeneca is the latest big pharma group to open up a Direct-To-Consumer (DTC) sales channel in the US, offering three of ...
MedPage Today on MSN
Asthma, COPD Inhalers Contributing More Greenhouse Gases
International asthma guidelines increasingly support the use of inhaled corticosteroid plus fast-acting β-agonist ...
A new study found that a 2-in-1 anti-inflammatory inhaler reduced asthma attacks in children by 45% compared to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results